Dr. Afzal Husain has had a diverse academic and professional career spanning molecular biology, biochemistry, and genome biology. His Ph.D. research, conducted under the guidance of Tomoyoshi Nozaki at Gunma University and the National Institute of Infectious Diseases, focused on identifying novel metabolic pathways in human protozoan parasites using multidisciplinary approaches, including metabolomics, transcriptomics, and enzymology, to aid chemotherapeutic development.

Following his Ph.D., Dr. Husain worked with Nobel Laureate Tasuku Honjo at Kyoto University, where he investigated AID-dependent antibody gene diversification and genome instability in B-cell lymphomas using chromatin proteomics and reverse genetics. This work further strengthened his expertise in molecular biology, immune responses, and DNA damage repair.

Dr. Husain later served as Research & Development Manager at Thermo Fisher Scientific in Bengaluru, leading projects in epigenetics and custom antibody development, including recombinant rabbit antibodies against small molecules, proteins, and post-translational modifications.

He has published in leading journals, including The EMBO Journal, Nature Communications, Proceedings of the National Academy of Sciences, Cell Reports, and Journal of Biological Chemistry. His current research focuses on the molecular mechanisms underlying genome instability.